AT
NASDAQ · ATHE
Alterity Therapeutics Limited
Healthcare · Biotechnology
$3.07
Up+$0.05 (+1.47%)
Updated Oct 9, 2026, 10:56 PM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 31.19M
- P/E ratio
- -4.93
- Dividend yield
- 0.00%
- 52-week range
- $3.04 – $5.89
- Volume
- 34.37K
- Avg. volume
- 14.18K
Price performance · ATHE
ATHE price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 8, 2026
ATHE closed at $3.07 after 21 trading sessions, down 25.30% for the selected period.
- Last close
- $3.07
- Period change
- -25.30%
- Period low
- $3.07
- Period high
- $4.11
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 8, 2026 | $3.21 | $3.3399 | $3.04 | $3.07 | 34.37K |
| Oct 7, 2026 | $3.41 | $3.51 | $3.29 | $3.32 | 19.34K |
| Oct 6, 2026 | $3.34 | $3.4574 | $3.22 | $3.37 | 21.86K |
| Oct 5, 2026 | $3.2899 | $3.29 | $3.10 | $3.22 | 54.64K |
| Oct 2, 2026 | $3.39 | $3.4588 | $3.25 | $3.45 | 47.17K |
| Oct 1, 2026 | $3.53 | $3.57 | $3.38 | $3.49 | 23.2K |
| Sep 30, 2026 | $3.47 | $3.87 | $3.4601 | $3.65 | 30.35K |
| Sep 29, 2026 | $3.50 | $3.8924 | $3.41 | $3.66 | 21.41K |
| Sep 28, 2026 | $3.60 | $3.60 | $3.495 | $3.50 | 10.41K |
| Sep 25, 2026 | $3.72 | $3.72 | $3.60 | $3.67 | 2.55K |
| Sep 24, 2026 | $3.61 | $3.99 | $3.61 | $3.77 | 5.82K |
| Sep 23, 2026 | $3.83 | $3.98 | $3.50 | $3.55 | 15.66K |
| Sep 22, 2026 | $3.7799 | $3.9999 | $3.75 | $3.78 | 11.83K |
| Sep 21, 2026 | $3.875 | $3.90 | $3.6501 | $3.78 | 11.4K |
| Sep 18, 2026 | $3.85 | $3.92 | $3.8001 | $3.91 | 3.09K |
| Sep 17, 2026 | $3.86 | $3.94 | $3.7219 | $3.75 | 10.67K |
| Sep 16, 2026 | $3.60 | $3.85 | $3.60 | $3.85 | 10.51K |
| Sep 15, 2026 | $3.85 | $3.85 | $3.50 | $3.50 | 14.57K |
| Sep 14, 2026 | $4.02 | $4.02 | $3.83 | $3.86 | 33K |
| Sep 11, 2026 | $4.15 | $4.33 | $4.05 | $4.05 | 22.3K |
| Sep 10, 2026 | $4.46 | $4.46 | $4.11 | $4.11 | 56.87K |
Latest ATHE news
The latest Smart Investors Daily articles mentioning ATHE.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…
